nai_header

nai_headerbuttons

HomeAbout NAIManufacturingNewsInvestor RelationsContact UsFAQFAQ
   About Us
   Executive Team
   Board of Directors
   Bus. Development
   
   Manufacturing
   Global Operations
   North America
   Europe & Asia
   Investors
   Financial Data
   Annual Report
   Corp. Governance
   
 
   Certifications
   TGA Certification
   GMP Standards
   Publications
   News & Blog
   News
   CEO's Blog
   Industry Links
   

Natural Alternatives International, Inc. Announces Expanded Commitment to the CarnoSyn® Brand and Previews SR CarnoSyn® Sustained Release Product Formulation

SAN MARCOS, Calif., Oct. 7, 2015 -- Natural Alternatives International, Inc. (NAI) (NASDAQ: NAII), a global formulator and manufacturer of customized nutritional supplements, announced its expanded commitment to CarnoSyn®, a studied, patent-protected beta-alanine ingredient for supporting an increase in muscle carnosine and athletic performance. As part of its commitment, NAI began to directly oversee the sales and distribution of CarnoSyn® in the United States and abroad as of April 1st, 2015. NAI is showcasing CarnoSyn® and previewing SR CarnoSyn® - a new sustained release beta-alanine powder - at the upcoming SupplySide West conference in Las Vegas, Nevada on October 5-9, 2015.

NAI is a global manufacturer recognized for its strong commitment to health, scientific integrity and quality, which extends to its CarnoSyn® brand. CarnoSyn® is backed by 55 clinical studies which demonstrate the positive effects of CarnoSyn® and SR CarnoSyn® supplementation. The CarnoSyn® brand is protected by NAI's growing portfolio of 14 patents in the United States and 10 abroad, which guarantee quality and exclusivity for the brand.

"NAI is investing significant resources towards building, promoting and protecting the CarnoSyn® brand, as well as supporting the upcoming launch of our new SR CarnoSyn® sustained release beta-alanine powder ," said Mark A. LeDoux, NAI's CEO and board chairman. "We're very excited to expand the CarnoSyn® portfolio of products and to work in partnership with both current and prospective partners to help drive business opportunities."

CarnoSyn® beta-alanine is a leading ingredient in sports nutrition formulations, supporting the synthesis of muscle carnosine, which acts as a buffer, delaying the onset of muscle fatigue and failure. Supplementing with CarnoSyn® beta-alanine, which combines with histidine in the body to form carnosine, significantly increases the levels of carnosine in the muscle. Carnosine's ability to buffer hydrogen ions keeps muscles contracting longer, which extends endurance, speeds muscle recovery, builds muscle strength and enhances peak performance capabilities.

SR CarnoSyn® beta-alanine provides formulation flexibility via a sustained release profile, extending the benefits of beta-alanine to a much broader group of consumers with active lifestyles. SR CarnoSyn® delivers higher levels of beta-alanine more comfortably in a single dose. SR CarnoSyn® results in a sustained beta-alanine release that stays in the body longer for carnosine synthesis. The net effect is higher muscle retention of carnosine. SR CarnoSyn® delivers much higher dosage levels than instant release CarnoSyn® before reaching the typical paresthesia-sensation threshold.

In an effort to fortify the CarnoSyn® brand and deliver additional value to its customers, NAI has expanded its commitment to the following areas of development:

  • Continued Research and Development: NAI will continue to fund and support additional clinical studies to further strengthen substantiation, future product claims, and an expanded product line
  • Robust B2B and B2C Marketing and Advertising Programs: NAI will commit substantial resources to help increase brand awareness and drive new business opportunities
  • Vigorous Patent Protection: NAI will continue to dedicate resources to track and enforce compliance with its patent rights
  • Inventory and Supply Control: NAI will continue to invest in robust inventory levels and supply chain support to guarantee material availability, ensure timely production and consistency in product safety and quality

NAI will exhibit in booth #1506 at SupplySide West, where it will preview a new sustained release powder delivery form, SR CarnoSyn®, which delivers higher levels of beta-alanine more comfortably in a single dose.
NAI's CEO and Chairman of the Board, Mark LeDoux, will also participate in a panel of industry influencers to discuss safety, regulatory, and consumer confidence issues for the supplement industry, which takes place on October 7th from 9-11am. For more information, please visit SupplySide Panel Discussions.

About Natural Alternatives International, Inc.

Natural Alternatives International, Inc. (NAI) is a leading formulator and manufacturer of customized nutritional supplements. The Company's comprehensive partnership approach to client servicing is unique within the industry, combining clinical research, science-based formulation, advanced quality assurance testing methodologies, superior manufacturing and packaging capabilities, and broad marketing experience to create nutritional products that are formulated to address specific health conditions.

Founded in 1980, NAI prides itself on a strong commitment to health, scientific integrity and quality. It provides comprehensive solutions that include custom formulations based on scientific research, the highest manufacturing standards, supervision of international regulatory compliance, and marketing support. It has established partnerships and works to develop tailored solutions for its clients' nutritional product needs. With state-of-the-art manufacturing facilities in Vista, California and Lugano, Switzerland, and a sales presence in Yokohama, Japan, NAI is able to fulfill the needs of its customers around the world.

This press release contains forward-looking statements within the meaning of applicable securities laws that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to our future financial and operating results, the outcome of pending litigation, the continued validity of our patents, and our ability to successfully develop, license and enforce our intellectual property rights. We wish to caution readers that these statements involve risks and uncertainties, that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI's financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

CONTACT – Michael Fortin, Chief Financial Officer, Natural Alternatives International, Inc., at 760-736-7700 or investor@nai-online.com